Natasja Toft Furman

Patent Attorney, CDPA

MSc Molecular Medicine

Natasja is part of our Life Science & Chemistry team, where she utilises her extensive knowledge in molecular biology, immunology, (epi)genetics, biotechnology, and organic chemistry, as well as pathology, to advise universities, start-ups, SMEs, and large corporations.

She has a particular expertise in vaccines, including vaccine adjuvants, cancer treatment, infertility treatment, plastic degradation, CO₂ capture processes, and novel drug delivery methods, including new nanoparticle compositions.

At Plougmann Vingtoft, Natasja works with all aspects of intellectual property rights (IPR), with a particular focus on drafting patentability assessments, patent applications, prosecution, and evaluations, including Freedom to Operate (FTO) analyses and patent monitoring, primarily within life sciences and pharmaceuticals. In addition, Natasja has experience in preparing and filing supplementary protection certificates (SPCs) and paediatric extensions of SPCs.

Natasja has an academic background in molecular medicine, where she has conducted research on the intersection between cancer and the immune system.

She has been part of Plougmann Vingtoft since 2022.